Research Focus

Our Commitment to Global Women’s Cancer Care

At the Center for Global Cancer Control, our journey commences with a vision. Whether you aspire to enhance healthcare access, elevate cancer research, or implement transformative educational frameworks, your ambition serves as our driving force. The impact of your mission can resonate globally, creating a lasting difference.

We understand that substantial advancements necessitate rigorous research aimed at large-scale transformational change. At the UC Center for Global Cancer Control - The Pinder Lab, we integrate women's oncology with global public health initiatives to develop and implement sustainable solutions. Our multifaceted approach ensures that we address not only the medical aspects of cancer care but also the social determinants of health that impact women globally. By prioritizing innovative research and collaborative partnerships, we strive to create a future where equitable cancer care is accessible to all women, irrespective of geographical or socio-economic barriers.

Current & Past Projects (including Collaborations)

US CURRENT:

• “CASCADE Research Bases for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network’”. NCI.
  • Learn more about CASCADE
• “Self-collection for HPV testing to Improve Cervical Cancer Prevention” (SHIP) Trial. NCI
  • Learn more about SHIP
• “Facing Race in Cancer Clinical Trials (FACCTs)”. UC Cancer Center
• “Improving Access to Cervical Cancer Screening: Integrating HPV Self-Testing into Cincinnati Healthcare (IMPACT 513)”. UC Dept. of OBGYN
  • Visit the Hamilton County 513Relief Bus Services site
• “A novel, one stop, affordable, point of care and artificial intelligence supported system of screening, triage and treatment selection for cervical cancer and precancer in the LMICs” (EASTER USA) NCI
  • Learn more about EASTER USA

ZAMBIA CURRENT:

• “CervALONE: A randomized, active controlled, assessors-blind trial to establish non-inferiority of immunogencity of a single-dose of VERAVAC quadrivalent HPV vaccine to compared to the Gardasil quadrivalent vaccine among girls and boys aged 9 to 14 years and girls and women aged 15 to 20 years in Zambia”. IARC
  • Learn more about CERVALONE
• “Repurposed Antiretroviral Therapies to Eliminate Cervical Cancer ‘POLESA’”. NCI
  • Learn more about POLESA

PAST:

• “Towards Cervical cancer elimination: Implementation and scale-up of a single-visit, screen-and-treat approach with thermal ablation for sustainable cervical cancer prevention services in Kenya”. NCI.
• “Automated Visual Evaluation (AVE) to improve cervical cancer screening: A prospective observational study in Zambia and Zimbabwe”. Clinton Health Access Initiative.
• “Evaluation of safety and efficacy of thermo-coagulation vs. cryotherapy to treat cervical precancers in HIV infected women through a Zambian RCT”. NCI.
• “Colaboracion Evita: HPV-Related Cancer Prevention Partnership Center”. NCI.
• “Development, field testing and evaluation of the efficacy of a hand-held, portable and affordable thermo-coagulator to prevent cervical cancer in low- and middle-income countries”. NCI.